Biotechnologia Acta

...

  • Increase font size
  • Default font size
  • Decrease font size
Home
Print PDF

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

"Biotechnologia Acta" V. 12, No 1, 2019
https://doi.org/10.15407/biotech12.01.066
Р. 66-74, Bibliography 39, English
Universal Decimal Classification: 57.044: 612.35

INFLUENCE OF C60-FULLERENE AQUEOUS COLLOID SOLUTION ON LIVER AND PANCREAS MORPHOLOGICAL STATE AND BLOOD AMINOTRANSFERASES OF RATS WITH EXPERIENCED ACUTE CHOLANGITIS

N. V. Dziubenko, H. M. Kuznietsova, O. V. Lynchak, V. K. Rybalchenko

Taras Shevchenko National University of Kyiv

Aim of the work was to investigate the suspended C60-fulleren effect on liver and pancreas state under intraperitoneal and intragastrial administration on rat experimental cholangitis model. Acute cholangitis was simulated by a single ingestion of ɑ-naphthyl isothiocyanate — ANIT. C60-fullerene aqueous colloid solution (C60FAS, 0.15 mg/ml) was administered to animals at a volume containing C60-fullerenes at a dose of 0.5 mg/kg body weight in 24 and 48 h after ANIT administration. After72 h of the experiment, the animals were euthanized. Blood serum ALT and AST activities were measured, the liver and pancreas states were analyzed by light-microscopy level. It was found that intragastrial and intraperitoneal administration of C60FAS contributes to the correction of negative effects in the liver and pancreas caused by the induction of acute cholangitis. This was proved by the normalization of ALT activity, reduction of pancreatic parenchymal edema and liver fibrosis, and increased blood flow in these organs. Application of C60FAS could improve the state of the liver and pancreas under acute cholangitis in rats.

Key words: C60-fullerene, acute cholangitis.

© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2019

  • References
    • 1. Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol. J. 2018, 28 (12), 26–32.

      1. Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol. J. 2018, 28 (12), 26–32.

      2. Gepatit B. http://www.who.int/ru/news-room/fact-sheets//hepatitis-b (In Russian).

      3. Gong D. Y., Chen E. Q., Huang F. J., Leng X. H., Cheng X., Tang H. Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivoViruses. 2013, 5 (5), 1261–1271. https://doi.org/10.3390/v5051261

      4. Global hepatitis report 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report.2017/en/.

      5. Hirzel C., Pfister S., Gorgievski-Hrisoho M., Wandeler G., Zuercher S. Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples. J. Clin. Virol. 2015, 33 (5). https://doi.org/10.1016/j.jcv.2015.05.024

      6. Li M., Xi H., Wang Q., Hou F., Huo N., Zhang X., Li F., Xu X. Kinetics of serum HBsAg in Chinese patients with chronic HBV infection with long-term adefovir dipivoxil treatment. Chin. Med. J. 2014, 127 (11), 2101–2104.

      7. Stasi S., Silvestri C., Berni R., Brunetto M. R., Zignego A. L., Orsini C., Milani S., Ricciardi L., De Luca A., Blanc P., Nencioni C., Aquilini D., Bartoloni A., Bresci G., Marchi S., Filipponi F., Colombatto P., Forte P., Galli A., Luchi S., Chigiotti S., Nerli A., Corti G., Sacco R., Car rai P., Ricchiuti A., Giusti M., Almi P., Cozzi A., Carloppi S., Laffi G., Voller F., Cipriani F. Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study. World J. Hepatol. 2018, 10 (5), 409–416. https://doi.org/10.4254/wjh.v10.i5.409

      8. Shil N., Rahman A., Sultana N., Yasmin F. Markers of hepatitis viruses by ELISA among healthy blood donors. Mymensingh. Med. J. 2015, 24 (4), 776–779.

      9. Hepatitis B and C Testing Guide, World Health Organization, 2017. http://apps.who.int//iris/ bitstream/ handle/10665/260130/9789244549988-rus.pdf. (In Russian).

      10. Hon J., Ren J., Song L., Zhao F., Liang P. Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer. J. Clin. Lab. Anal. 2018, 32 (1). https://doi.org/10.1002/jcla.22159

      11. Mostovich L. A., Bezuglova L. V., Jaroslavceva O. A., Faranosova O. N., Netesova I. G. HBsAg serovariants and the evolution of tests to identify it. http://www.fadlab.ru/.../mostovich-la-serovarianty-hbsag-22-okt-2015-khmao.pd. (In Russian).

      2. Gepatit B. http://www.who.int/ru/news-room/fact-sheets//hepatitis-b (In Russian).

      3. Gong D. Y., Chen E. Q., Huang F. J., Leng X. H., Cheng X., Tang H. Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivoViruses. 2013, 5 (5), 1261–1271. https://doi.org/10.3390/v5051261

      4. Global hepatitis report 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report.2017/en/.

      5. Hirzel C., Pfister S., Gorgievski-Hrisoho M., Wandeler G., Zuercher S. Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples. J. Clin. Virol. 2015, 33 (5). https://doi.org/101016/j.jcv.201505.024

      6. Li M., Xi H., Wang Q., Hou F., Huo N., Zhang X., Li F., Xu X. Kinetics of serum HBsAg in Chinese patients with chronic HBV infection with long-term adefovir dipivoxil treatment. Chin. Med. J. 2014, 127 (11), 2101–2104.

      7. Stasi S., Silvestri C., Berni R., Brunetto M. R., Zignego A. L., Orsini C., Milani S., Ricciardi L., De Luca A., Blanc P., Nencioni C., Aquilini D., Bartoloni A., Bresci G., Marchi S., Filipponi F., Colombatto P., Forte P., Galli A., Luchi S., Chigiotti S., Nerli A., Corti G., Sacco R., Car rai P., Ricchiuti A., Giusti M., Almi P., Cozzi A., Carloppi S., Laffi G., Voller F., Cipriani F. Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study. World J. Hepatol. 2018, 10 (5), 409–416. https://doi.org/10.4254/wjh.v10.i5.409

      8. Shil N., Rahman A., Sultana N., Yasmin F. Markers of hepatitis viruses by ELISA among healthy blood donors. Mymensingh. Med. J. 2015, 24 (4), 776–779.

      9. Hepatitis B and C Testing Guide, World Health Organization, 2017. http://apps.who.int//iris/ bitstream/ handle/10665/260130/9789244549988-rus.pdf. (In Russian).

      10. Hon J., Ren J., Song L., Zhao F., Liang P. Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer. J. Clin. Lab. Anal. 2018, 32 (1). https://doi.org/10.1002/jcla.22159.

      11. Mostovich L. A., Bezuglova L. V., Jaroslavceva O. A., Faranosova O. N., Netesova I. G. HBsAg serovariants and the evolution of tests to identify it. http://www.fadlab.ru/.../mostovich-la-serovarianty-hbsag-22-okt-2015-khmao.pd. (In Russian).


 

Additional menu

Site search

Site navigation

Home

Invitation to cooperation

Dear colleagues, we invite you to publish your articles in our journal.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2008.
All rights are reserved. Complete or partial reprint of the journal is possible only with the written permission of the publisher.
E-mail
for information: biotech@biochem.kiev.ua.